Neurotransmitter transporters in the central nervous system.
about
The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disordersMolecular cloning and functional characterization of human vesicular glutamate transporter 3.X-ray structure of dopamine transporter elucidates antidepressant mechanismDual dopamine/serotonin releasers: potential treatment agents for stimulant addictionDual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsTrace amine-associated receptor 1 as a monoaminergic modulator in brainFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansUnfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacyNeurotransmitter transporters and their impact on the development of psychopharmacologyHow LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transportersA competitive inhibitor traps LeuT in an open-to-out conformation.Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like contextSaccharomyces cerevisiae Aqr1 is an internal-membrane transporter involved in excretion of amino acidsMutation K448E in the external loop 5 of rat GABA transporter rGAT1 induces pH sensitivity and alters substrate interactionsNipecotic acid directly activates GABA(A)-like ion channelsPrenatal antidepressant exposure: clinical and preclinical findings.Memory-specific temporal profiles of gene expression in the hippocampusNeurotransmitter Transporter-Like: a male germline-specific SLC6 transporter required for Drosophila spermiogenesis.Substrate binding and formation of an occluded state in the leucine transporter.Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6.Global gene expression profiling of healthy human brain and its application in studying neurological disorders.Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter.Regulation of neuronal function by protein trafficking: a role for the endosomal pathway.GABA uptake into astrocytes is not associated with significant metabolic cost: implications for brain imaging of inhibitory transmission.Discovery of novel selective serotonin reuptake inhibitors through development of a protein-based pharmacophore.Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.GABA and neuroactive steroid interactions in glia: new roles for old players?Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus.Is there a SERT-ain association with IBS?Mass-spectrometric studies of new 6-nitroquipazines-serotonin transporter inhibitorsSynthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophreniaMechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter.Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.Pentameric assembly of a neuronal glutamate transporter.Appetite suppressants, cardiac valve disease and combination pharmacotherapyTetrabenazine (Xenazine), An FDA-Approved Treatment Option For Huntington's Disease-Related Chorea.
P2860
Q22241325-8A718EE6-0173-4E98-8F34-C98D01BC2F4CQ24522650-7502E437-37FF-4892-A2F2-BCE8E5F23661Q24612997-EDEFE6E0-4A9D-44E5-AD89-DB2F039B343BQ24641896-95CC0434-4949-47AE-A92D-C6B9D759AE89Q24647786-22BFD558-DEFD-48E7-9FED-D72DF5186AD8Q24650242-649D805F-4F84-42A3-8FF5-4294F04801BCQ24654140-34394B27-A998-44AF-B316-65EDF8C730B1Q24658095-80343538-1C6B-4FA1-98A3-D1C8AFD53F83Q24670273-AEDD084A-EA49-4153-85D0-BA5F5010B39DQ26866308-C89933F4-DF81-4DCA-9580-5D27F6BC467DQ27653127-0A8D53F9-03F3-47FB-BE7C-27D1DFDFC4FDQ27676749-D5B0E5E1-1C1B-45AD-AC49-47D5C516336CQ27931298-FE88AC66-925D-43FA-8D4F-6A478A64D0DEQ28361683-7028C900-1119-4692-9DB0-23CF513792B3Q28367876-6395817E-8689-4A4F-93A6-07F7ECD87550Q30415540-E56DCD99-4A09-47FB-90B5-C8E6C3CF2CC1Q30476907-62BBAE4B-1005-40B8-91A9-F552B5FB9D32Q30477158-A1C9C6F5-F2D2-4E55-ABD9-CA456B19A7BBQ30481294-6CE979B5-FB44-4136-8CA1-838A0B3592E2Q33654253-1CF3FD74-DC0F-4482-9954-B465A0502002Q33678602-BA86C877-14DA-4E0E-BD78-C46D4BEDE3FCQ33707171-D56BAF83-B24A-471C-B0BD-83D5EB37201AQ33919090-EF0D91CB-EDAC-4C87-844D-FD923793C644Q33973012-A4196A68-480F-495F-850F-A97039714E4CQ33990707-4353DF27-4F21-4E91-82C8-9CC4664B4630Q34320147-BFF7C84E-2855-4B55-9ACC-3871DAE01182Q34794249-DD5CF5FD-EE4E-42E6-A7F1-48A1CDCB2CACQ35011459-72F440CF-42FE-4D36-9F5A-323E88C3060AQ35143996-DD8DD2E9-7422-4292-8F0D-C3A4E33F8F0EQ35596897-E0A10026-550F-4DD6-878F-88B91BE01C03Q35645551-01A1EB90-3A76-472C-90D0-AD5478E13A91Q36002440-BBB17689-CC8F-471A-8BFE-A9A2666A69B7Q36507158-B8D44876-D316-4C69-A215-6EEFE71A1D23Q36598124-48FC2D7D-FCA1-4631-98F7-66B4CC905228Q36609289-5F12E4F9-A8D0-4E62-9B91-78B16AA620F1Q36754967-45999FC8-9410-4945-B810-3C367860F063Q37129963-0E39E9B7-F90D-4979-A23E-D1037440C569Q37236922-32715C8F-9414-4403-AAB8-1EF24A4F067BQ37268774-C4B54B7A-AE46-4802-9925-54C89322CA0BQ37315584-FBA39B4A-FFF3-4C58-A668-AD9AB17342C8
P2860
Neurotransmitter transporters in the central nervous system.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neurotransmitter transporters in the central nervous system.
@ast
Neurotransmitter transporters in the central nervous system.
@en
type
label
Neurotransmitter transporters in the central nervous system.
@ast
Neurotransmitter transporters in the central nervous system.
@en
prefLabel
Neurotransmitter transporters in the central nervous system.
@ast
Neurotransmitter transporters in the central nervous system.
@en
P2093
P1476
Neurotransmitter transporters in the central nervous system.
@en
P2093
P304
P577
1999-09-01T00:00:00Z